100 Translational Medicine associated with RTA 502
Login to view more data
100 Patents (Medical) associated with RTA 502
Login to view more data
1
Literatures (Medical) associated with RTA 502
01 Nov 2007·Journal of medicinal chemistryQ1 · MEDICINE
Optimization of Naphthalimide-imidazoacridone with Potent Antitumor Activity Leading to Clinical Candidate (HKH40A, RTA 502)
Q1 · MEDICINE
Article
Author: Tarasova, Nadya I. ; Kosakowska-Cholody, Teresa ; Michejda, Christopher. J. ; Hariprakasha, Humcha K. ; Stinson, Sherman F. ; Meyer, Colin ; Cholody, Wieslaw M.
Unsymmetrical bifunctional antitumor agent WMC79 was further optimized to generate compound 7b that not only inhibited the growth of many tumor cell lines, but caused rapid apoptosis. Unlike the parent compound, 7b is toxic to both p53 positive and negative cancer cells. It has potent in vivo activity against xenografts of human colon and pancreatic tumors in athymic mice.
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.